Yeah, I've been watching GTBP for a while now, I like how they're starting to diversify their treatments and attacking different niches. Over the last year, the company has done a great job improving their management team with experienced industry veterans who have big pharma experience and have taken drugs from trials to market. Something very uncommon in a lot of other OTC biotechs from my experience.
News 
Market Data 
Discover 
